Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Kaposi 1HIV Infections 1AIDS-related Kaposi sarcoma 1

Interventions

Valganciclovir 3Specimen Handling 3Magnetic Resonance Spectroscopy 3Biopsy 3Bevacizumab 3technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2Nivolumab 2tocilizumab 1pomalidomide 1pembrolizumab 1liposomal doxorubicin 1emvododstat 1efineptakin alfa 1cabozantinib 1Zidovudine 1Sunitinib 1Polymerase Chain Reaction 1Nelfinavir 1Maraviroc 1Lenalidomide 1Ipilimumab 1Immunohistochemistry 1Imatinib Mesylate 1HhAntag691 1Gene Expression Profiling 1Etoposide 1Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1CTLA-4 Antigen 1Antiretroviral Therapy, Highly Active 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Sarcoma, Kaposi × emvododstat × Clear all
NCT00686842 2018-06-06

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 1/2 Terminated
17 enrolled 7 charts
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡